Retrospective study of coronary uptake of18F-fluorodeoxyglucose in association with calcification and coronary artery disease: A preliminary study

Nuclear Medicine Communications

Volumn 30, Issue 4, 2009, Pages 287-291

  Williams, Gethin ^a   Kolodny, Gerald M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

18F fluorodeoxyglucose; Calcinosis; Coronary artery calcification; Coronary artery disease; Positron emission tomography; Tomography X ray computed

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; RETROSPECTIVE STUDY; SCINTIANGIOCARDIOGRAPHY;

ADULT; AGED; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIET; DIET, CARBOHYDRATE-RESTRICTED; DIETARY FATS; DIETARY PROTEINS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED; YOUNG ADULT;

EID: 63149176591     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328328bfc3     Document Type: Article

References (18)

1. Ben-Haim S, Kupzov E, Tamir A, Israel O. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 2004; 45:1816-1821.
2. 18F]- fluorodeoxyglucose positron emission tomography. Circulation 2002; 105:2708-2711.
3. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 2003; 229:831-837.
4. 18F-FDG PETcoregistered with enhanced CT. J Nucl Med 2005; 46:917-922.
5. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19:61-77.
6. De Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005; 32:98-101.
7. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low- carbohydrate diet. Am J Roentgenol 2008; 190:W151-W156.
8. Frayn KN. The glucose-fatty acid cycle: a physiological perspective. Biochem Soc Trans 2003; 31:1115-1119.
9. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994; 93:2438-2446.
10. Armoni M, Harel C, Bar-Yoseph F, Milo S, Karnieli E. Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements. J Biol Chem 2005; 280:34786-34795.
11. 18F-FDG uptake with vascular calcification. J Nucl Med 2005; 46:1278-1284.
12. 18F fluorodeoxyglucose uptake on follow-up PET/CT studies. J Nucl Cardiol 2006; 13:791-800.
13. Libby P. Atherosclerosis: disease biology affecting the coronary vasculature. Am J Cardiol 2006; 98:30.-90.
14. Fu Y, Maianu L, Melbert BR, Garvey WT. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Stood Cells Mol Dis 2004; 32:182-190.
15. Boden G, Shulman Gl. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002; 32 (Suppl 3):14-23.
16. 18FDG PET/CT in patients with suppression of myocardial uptake using a low carbohydrate, high fat preparation JNM (submitted).
17. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Amer Coll Cardiology 2006; 48:1818-1824.
18. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006; 48:1825-1831.